NuPathe wins NOA for migraine patch from USPTO
NuPathe has received a notice of allowance (NOA) for its migraine patch patent application 12/142,604 from the US Patent and Trademark Office (USPTO).
The application relates a migraine patch (NP101 or Zelrix) which delivers sumatriptan using an iontophoretic technique to achieve consistent therapeutic plasma levels with low patient-to-patient variability to treat migraine.
The patch uses the comapny's proprietary transdermal delivery technology, SmartRelief, that allows the rapid yet tightly controlled transport of medication through the skin.
NuPathe said once the patent is issued, it will provide additional patent protection through April 2027 for its migraine patch.
NuPathe CEO Jane Hollingsworth said issuance of this patent will further strengthen their intellectual property related to NP101.
"We look forward to re-submitting our NDA for the migraine patch in the first half of this year," Hollingsworth said.
Related Insight
Suppliers Directory
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Drug Delivery Devices Intelligence
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500
Comments may be moderated for spam, obscenities or defamation.